![]() The platform enables healthcare systems to forecast and predict demand and manage how and where care is merchandized to consumers – throughout the digital ecosystem. The funding round included participation from existing partners Transformation Capital, Kaiser Permanente Ventures, Define Ventures, Frist Cressey Ventures, and SpringRock Ventures.ĭexCare is a care-access platform to manage the logistics of digital-care delivery. Together, DexCare and its partners have the runway to modernize the legacy data-and-platform infrastructures to realize a healthcare ecosystem that works for everyone. The addition of ICONIQ Growth – who has partnered with companies defining the future of their industries like Adyen, Datadog, GitLab, Miro, and Snowflake – brings a track record of disruption and positive change. ![]() With the backing of our investors, partners and customers, we’re overhauling an antiquated industry to ensure patients are matched to the right provider, at the right time, and in the right setting." "We’re staring at a new era of care delivery," said Streat, "and this financing validates DexCare’s impact to modernize health commerce, from how care is accessed and orchestrated to delivered. The pandemic taught us that consumers want convenience and choice, and that health systems need controls to manage the supply of care – DexCare delivers both. "The trauma caused on the frontlines, as health systems rushed to care for their communities, stressed an already high level of provider and nurse burnout. healthcare system," said Derek Streat, CEO of DexCare. "We’re just emerging from an unpredictable moment in history that cast a spotlight on a strained U.S. The new funding brings the total raised to $146 million, including two oversubscribed rounds closed in less than two years. The funding will advance DexCare’s platform, which extends limited health-system capacity to serve patients faster and to precisely manage the supply and demand of digital-care access. SEATTLE, June 21, 2023-( BUSINESS WIRE)- DexCare, Inc., the leading patient demand and care access platform, today announced the close of its $75 million Series C funding round led by ICONIQ Growth. healthcare systems capture consumers, manage limited resources, and control costs to fuel growth Funding will advance DexCare’s product portfolio of innovation to help U.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |